SMTL ID : 4cyp.1

Leishmania major N-myristoyltransferase in complex with a pyrrolidine inhibitor.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 7 residues within 4Å: Chain A: L.165, R.166, E.167, K.168, R.169, L.170 Ligands: MYA.3 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:L.165

1 x A62: (3R)-4-(4-CHLOROPHENYL)-1-[(3S,4R)-3-(4-CHLOROPHENYL)-4-(HYDROXYMETHYL)PYRROLIDIN-1-YL]-3-HYDROXYBUTAN-1-ONE(Non-covalent)

A62.2: 19 residues within 4Å: Chain A: Y.70, V.71, F.80, Y.82, N.157, T.193, G.195, Y.207, F.208, H.209, Y.316, I.318, Y.335, N.366, M.367, L.389, M.410, L.411 Ligands: MYA.3 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.71, A:V.71, A:F.80, A:Y.207, A:Y.207, A:N.366, A:L.389, A:M.410 Hydrogen bonds: A:Y.82, A:T.193, A:T.193 Water bridges: A:N.157 pi-Stacking: A:Y.335 Halogen bonds: A:F.208

1 x MYA: TETRADECANOYL-COA(Non-covalent)

MYA.3: 33 residues within 4Å: Chain A: H.2, A.3, F.4, W.5, N.69, Y.70, V.71, I.156, N.157, F.158, L.159, C.160, V.161, R.166, E.167, K.168, R.169, L.170, A.171, P.172, T.179, V.182, N.183, W.188, Q.189, A.190, Y.192, T.193, A.194, L.198, Y.394 Ligands: MG.1, A62.2 27 PLIP interactions: 27 interactions with chain A Hydrophobic interactions: A:Y.70, A:V.71, A:I.156, A:L.159, A:L.159, A:V.161, A:T.179, A:V.182, A:A.190, A:Y.192, A:Y.394 Hydrogen bonds: A:A.3, A:F.4, A:W.5, A:Y.70, A:F.158, A:L.159, A:L.159, A:V.161, A:R.166, A:E.167, A:R.169, A:A.171 Water bridges: A:R.169 Salt bridges: A:H.2, A:R.169, A:R.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hutton, A. et al., Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors. J.Med.Chem. (2014)

Release Date

2014-10-22

Peptides

GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE

Related Entries With Identical Sequence